Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calkin

Showing results (181-190 of 256) with videos related to

Pageof 26
Sort By:
Journal of Clinical Psychopharmacology|February 29, 2024
Predicting Conversion to Insulin Sensitivity With Metformin: A Promising Tool for Clinicians in Addressing Insulin Resistance and Improving Outcomes in Patients With Treatment Resistant Bipolar DepressionJessica M Gannon, Marcos Sanchez, Katherine Lines, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2011
FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptorsAnna C Calkin, Benjamin T Goult, Li Zhang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2006
PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouseAnna C Calkin, Sara Giunti, Karin A Jandeleit-Dahm, et al.
The Journal of Endocrinology|September 19, 2023
Loss of Trim28 in muscle alters mitochondrial signalling but not systemic metabolismEmily J King, Simon T Bond, Christine Yang, et al.
Current Pharmaceutical Design|September 28, 2007
PPARs and diabetes-associated atherosclerosisA C Calkin, K A Jandeleit-Dahm, E Sebekova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2025
Wildfires have created instability within risk transfer markets. Here's a path forwardMatthew P Thompson, David E Calkin, Donald M MacGregor, et al.
Journal of Environmental Management|July 6, 2014
Wildfire exposure and fuel management on western US national forestsAlan A Ager, Michelle A Day, Charles W McHugh, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2004
Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout miceMarkus Lassila, Karin Jandeleit-Dahm, Kwee K Seah, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 18, 2014
Insulin resistance and outcome in bipolar disorderCynthia V Calkin, Martina Ruzickova, Rudolf Uher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effectsAnna C Calkin, Josephine M Forbes, Craig M Smith, et al.
Pageof 26

Showing results (181-190 of 256) with videos related to

Sort By:
Pageof 26
Journal of Clinical Psychopharmacology|February 29, 2024
Predicting Conversion to Insulin Sensitivity With Metformin: A Promising Tool for Clinicians in Addressing Insulin Resistance and Improving Outcomes in Patients With Treatment Resistant Bipolar DepressionJessica M Gannon, Marcos Sanchez, Katherine Lines, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2011
FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptorsAnna C Calkin, Benjamin T Goult, Li Zhang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2006
PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouseAnna C Calkin, Sara Giunti, Karin A Jandeleit-Dahm, et al.
The Journal of Endocrinology|September 19, 2023
Loss of Trim28 in muscle alters mitochondrial signalling but not systemic metabolismEmily J King, Simon T Bond, Christine Yang, et al.
Current Pharmaceutical Design|September 28, 2007
PPARs and diabetes-associated atherosclerosisA C Calkin, K A Jandeleit-Dahm, E Sebekova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2025
Wildfires have created instability within risk transfer markets. Here's a path forwardMatthew P Thompson, David E Calkin, Donald M MacGregor, et al.
Journal of Environmental Management|July 6, 2014
Wildfire exposure and fuel management on western US national forestsAlan A Ager, Michelle A Day, Charles W McHugh, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2004
Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout miceMarkus Lassila, Karin Jandeleit-Dahm, Kwee K Seah, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 18, 2014
Insulin resistance and outcome in bipolar disorderCynthia V Calkin, Martina Ruzickova, Rudolf Uher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effectsAnna C Calkin, Josephine M Forbes, Craig M Smith, et al.
Pageof 26